NDC 73372-0116 – Scenesse

Afamelanotide 16 mg/16mg · Implant · Subcutaneous

Human Prescription Drug

Product NDC73372-0116

Product details

Brand name
Scenesse
Generic name
afamelanotide
Labeler
CLINUVEL INC.
Dosage form
Implant
Route
Subcutaneous
Marketing category
NDA · NDA210797
Marketed since
December 31, 2019
Listing expires
December 31, 2027

Active ingredients

Uses, dosage, side effects and warnings for Scenesse →

Package NDC codes (1)

Package NDCDescriptionSince
73372-0116-11 VIAL, GLASS in 1 CARTON (73372-0116-1) / 1 mg in 1 VIAL, GLASSDec 31, 2019